Baebies
Baebies develops and offers innovative platforms like SEEKER and FINDER for newborn and pediatric testing, utilizing advanced digital microfluidics technology.
Services
Baebies specializes in newborn and pediatric testing using advanced screening platforms. Their service offerings include the SEEKER platform for newborn screening and the FINDER platform for near-patient testing. Both platforms utilize cutting-edge digital microfluidics technology to deliver fast and accurate results. SEEKER can perform multiple assays simultaneously on a single dried blood spot specimen, while FINDER operates with just 50 microliters of blood and provides results in approximately 15 minutes. These services aim to provide same-day reporting of results, enhancing the efficiency of newborn screening programs.
Products
Baebies offers two main products for screening and testing: the SEEKER and FINDER platforms. The SEEKER platform is designed for newborn screening and boasts FDA approval and CE marking. It is capable of performing multiple assays simultaneously from a single dried blood spot specimen. The FINDER platform is geared towards near-patient testing and also holds CE marking and US FDA clearance. It operates on a small blood sample of 50 microliters and delivers results in approximately 15 minutes, facilitating rapid diagnostic decisions.
Technologies
Baebies utilizes advanced digital microfluidics technology in their SEEKER and FINDER platforms. This technology allows for precise manipulation of very small fluid volumes, enabling high throughput screening processes. The digital microfluidics technology supports multiple simultaneous assays on the SEEKER platform, while the FINDER platform benefits from its rapid and efficient testing capabilities using minimal blood samples. This innovative approach enhances the accuracy and speed of newborn and pediatric testing.
Awards
Baebies has been recognized for its innovation in the field of newborn and pediatric testing with the 2020 AACC Disruptive Technology Award. This accolade highlights the company's pioneering work and its impactful contributions to improving testing methodologies and outcomes for newborns and pediatric patients. The award underscores Baebies' commitment to advancing medical technologies that enhance early diagnosis and treatment.